Bilastine
💊 Brand Formulations & Prices
80 brands sorted by unit price
Mayfair
Bilargo ODT
Blix
Elargen
Bilamin Kids
Blextin
Allertin ODT
Biltop
Allertin
Belas
Beltas
Beltas Kids
Bilaben
Bilabil
Bilahist
Bilamin
Bilan
Bilan Kids
Bilanex
Bilargo
Bilasi
Bilastin Kids
Bilaten
Bilatis
Bilaxe
Bilbest
Bilfast
Bilfast Kids
Bilgate
Bilista
Bilista Kids
Billi
Billi Meltab
Bilosen
Biltin
Biltin
Bilxen
Bislor
Blast
Blast
Blextin
Bteen
Byloza
Fixtat
Mylastin
Obila
Obila ODT
Opexa
Opexa ODT
Rinobil
Tinabil
Tinabil Kids
Zilas
Zilas
Bilastin
Bilergy
Rinobil
Bilfast
Bilabil
Bilan
Bilargo
Bilista
Zilas
Allertin
Bilbest
Bilosen
Bilahist
Bilasi
Bilastin
Opexa
Beltas
Bilamin
Bilanex
Bilaten
Bilatis
Billi
Biltin
Bilxen
Blast
Tinabil
📖 Official Clinical Monograph
DGDA Approved Prescribing GuidelinesAllertin is indicated for the symptomatic treatment of-
Allergic rhino conjunctivitis (seasonal and perennial) and
Urticaria
Allertin is also used to relieve the symptoms of hay fever (sneezing, itchy, runny, blocked-nose and red and watery eyes).
Adults & adolescents (12 years of age and over)
: 20 mg tablet once daily for symptomatic relief of allergic rhinitis, urticaria and allergic rhinoconjunctivitis. The maximum recommended daily dose is 20 mg Bilastine (1 tablet) and should not be exceeded. If a dose is missed, the next scheduled dose should be taken. An extra dose should not be taken. 20 mg Bilastine tablet (1 tablet) once daily should be swallowed with water on an empty stomach to achieve optimal exposure to Bilastine.
Children between 6 to 11 years
: 10 mg mouth dissolving tablet for the symptomatic relief of allergic rhinitis, allergic rhinoconjunctivitis and urticaria. The Mouth dissolving tablet is for oral use only. It should be placed in the mouth. It will disperse rapidly in saliva and can be easily swallowed. Alternatively, the mouth dissolving tablet can be dispersed in a tea spoon of water before being swallowed by the children. The maximum recommended daily dose for children in between 6 to 11 years is 10 mg Bilastine mouth dissolving tablet (1 tablet) and should not be exceeded. If a dose is missed, the next scheduled dose should be taken. An extra dose should not be taken.
Children between 2 to 11 years
: 4 ml once daily.
Bilastine is contraindicated in patients with hypersensitivity to the active substance or to any of the excipients of the tablet.
The most commonly reported side effects in clinical trial are headache, dizziness, somnolence and fatigue. These adverse events occurred with a comparable frequency in patients receiving placebo.
Treatment with Allertin 20 mg does not affect the driving performance. However, patients should be informed that very rarely some people experience drowsiness, which may affect their ability to drive or use machines. In clinical trials elderly patients (≥65 years) showed no difference in effcacy or safety with respect to younger patients. The maximum plasma concentration of Allertin after administration of 20 mg in patients with severe renal impairment is below the safety threshold of most common adverse e?ects and cardiac or CNS safety. No dosage adjustment is necessary in patients with renal impairment. Allertin is not metabolized in human. Since renal elimination is the major excretion, biliary excretion is expected to be only marginally involved in the elimination of Allertin. Changes in liver function are not expected to have a clinically relevant influence.
Bilastine is a potent, effective, non-sedating, long-acting histamine antagonist with selective & high affinity to H1 receptor (3 times higher than Cetirizine and 5 times higher than Fexofenadine). Even at a high concentration, Bilastine does not show affinity for the 30 other receptors including muscarinic, serotonergic, dopaminergic and noradrenergic receptors, for the other histamine receptor subtypes (H2, H3 and H4). It shows excellent safety profile and very favorable pharmacokinetic characteristics. Bilastine doesn’t undergo any metabolism to be active. Bilastine is excreted by feces (non -systemic) & urine (systemic) approximately 66.35% & 28.31% respectively.